DGEYX
Price
$20.53
Change
-$0.21 (-1.01%)
Updated
Sep 6 closing price
RNWFX
Price
$79.55
Change
-$1.12 (-1.39%)
Updated
Sep 6 closing price
Ad is loading...

DGEYX vs RNWFX

Header iconDGEYX vs RNWFX Comparison
Open Charts DGEYX vs RNWFXBanner chart's image
BNY Mellon Global Emerging Mkts - Y
Price$20.53
Change-$0.21 (-1.01%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$79.55
Change-$1.12 (-1.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DGEYX vs RNWFX Comparison Chart
Loading...
VS
DGEYX vs. RNWFX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGEYX is a Sell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.1B vs. DGEYX (406M). RNWFX pays higher dividends than DGEYX: RNWFX (1.51) vs DGEYX (1.00). DGEYX was incepted earlier than RNWFX: DGEYX (11 years) vs RNWFX (22 years). DGEYX is a more actively managed with annual turnover of: 44.72 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than DGEYX: RNWFX (250) vs DGEYX (1000000). RNWFX annual gain was more profitable for investors over the last year : 11.53 vs. DGEYX (5.04). DGEYX return over 5 years is better than : 37.07 vs. RNWFX (22.38).
DGEYXRNWFXDGEYX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years22 years-
Gain YTD2.8777.24540%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets406M60.1B1%
Annual Yield % from dividends1.001.5166%
Returns for 1 year5.0411.5344%
Returns for 3 years-26.92-15.44174%
Returns for 5 years37.0722.38166%
Returns for 10 years39.2235.71110%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGO16.410.29
+1.80%
Eldorado Gold Corp
BIP31.38-0.08
-0.25%
Brookfield Infrastructure Partners LP
KTRA0.17N/A
-2.51%
Kintara Therapeutics
LCTX0.87-0.03
-3.17%
Lineage Cell Therapeutics
NUVB2.88-0.13
-4.32%
Nuvation Bio